1/19
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Cancer starts with
uncontrolled growth of 1 cell
Coley’s Toxin
Successfuly injected streptococcal organisms into patient with inoperable cancer and tumour disappeared
Limitations of surgery
not possible to target all tumours
can be disfiguring
cancer can spread via blood and lymph systems
Limitations of radiation
only effective if cancer is localized
can burn and scar
can cause death
Chemotherapy
chemical that can travel in body and destroy tumour
limitations of chemotherapy
few chemicals specific for cancerous cells
can cause secondary cancers
Cause of cancer: chemicals
smoking
Cause of cancer: genes
hereditary cancer incidence
ex. BRCA1 mutation
Oncogenes
gene that cause cancer
dysregulation of oncogenes and tumour suppressor genes
can cause a cell to become cancerous
Her2
protein that can caue breast cancer cells to grow quickly
Herceptin
monoclonal antibody that binds to Her2 and blocks its signal to keep cells growing and increases ability of immune system to eliminate Her2+ cells
Why is cancer still very prevalent
high mutation rate resists chemotherapy
not all mutations drive cancer: difficult to identify essential genes
Aspects of immune system that can fight cancer
vaccination
treatment with monoclonal antibodies
Stephen Rosenburg
showed that lymphhocytes from respected melanomas can be expended in vitro and transferred back into patients, which can elicit tumour regression
Co-stimulation
When T cells are activated by DCs, TCR engagement must occur
second co-stimulatory signal from via CD80 and CD87 on DCs bind CD28 on T cells for full activation
CD80 and CD86 also bind CTLA4
CTLA4 signalling
limits T cell proliferation and activation
limits IL-2 production
Blocking CTLA4 in tumour with monoclonal antibodies
limits tumour growth
Cancer immunity cycle
release of cancer cell antigens → cancer antigen presentation → priming and activation → trafficking of T cells to tumours → infiltration of T cells into tumours → recognition of cancer cells by T cells → killing of cancer cells
Cancer immunity cycle cont.
Accumulation of activated T cells in and through stroma → interaction with immune cells → maintained effector state and function